News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,956 Results
Type
Article (15186)
Company Profile (299)
Press Release (268465)
Multimedia
Podcasts (79)
Webinars (11)
Section
Business (80291)
Career Advice (209)
Deals (13434)
Drug Delivery (40)
Drug Development (50837)
Employer Resources (42)
FDA (5911)
Job Trends (5239)
News (145908)
Policy (10144)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (937)
Accelerated approval (19)
Adcomms (14)
Allergies (82)
Alliances (21940)
ALS (124)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (241)
Approvals (6102)
Artificial intelligence (271)
Autoimmune disease (111)
Automation (9)
Bankruptcy (105)
Best Places to Work (4614)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (102)
Brain cancer (46)
Breast cancer (345)
Cancer (3140)
Cardiovascular disease (243)
Career advice (185)
Career pathing (7)
CAR-T (220)
CDC (5)
Cell therapy (570)
Cervical cancer (14)
Clinical research (43781)
Collaboration (1154)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1110)
CRISPR (86)
C-suite (553)
Cystic fibrosis (112)
Data (4334)
Denatured (16)
Depression (92)
Diabetes (255)
Diagnostics (1430)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (11)
Drug discovery (189)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31722)
Editorial (25)
Employer branding (5)
Employer resources (39)
Events (51859)
Executive appointments (625)
FDA (7675)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (991)
Gene editing (184)
Generative AI (21)
Gene therapy (488)
GLP-1 (507)
Government (1163)
Grass and pollen (3)
Guidances (167)
Healthcare (6731)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (66)
Infectious disease (1215)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (25)
IPO (7369)
IRA (12)
Job creations (886)
Job search strategy (164)
JPM (40)
Kidney cancer (9)
Labor market (25)
Layoffs (243)
Leadership (9)
Legal (1406)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (248)
Machine learning (24)
Management (13)
Manufacturing (379)
MASH (131)
Medical device (2760)
Medtech (2769)
Mergers & acquisitions (6689)
Metabolic disorders (726)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1954)
Neurotech (1)
NextGen: Class of 2026 (2067)
Non-profit (907)
Now hiring (30)
Obesity (329)
Opinion (133)
Ovarian cancer (131)
Pain (103)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (12)
Patents (304)
Patient recruitment (327)
Peanut (44)
People (26794)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15491)
Phase 2 (20311)
Phase 3 (12893)
Pipeline (3265)
Policy (91)
Postmarket research (857)
Preclinical (6543)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (240)
Rare diseases (650)
Real estate (1467)
Recruiting (18)
Regulatory (9963)
Reports (19)
Research institute (985)
Resumes & cover letters (26)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (184)
Series B (135)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2022)
State (1)
Stomach cancer (6)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (338)
Venture capital (71)
Weight loss (173)
Women's health (26)
Worklife (3)
Date
Last 7 days (347)
Last 30 days (1213)
Last 365 days (17908)
2026 (1661)
2025 (18213)
2024 (20720)
2023 (22571)
2022 (26979)
2021 (28013)
2020 (23579)
2019 (16446)
2018 (11893)
2017 (13848)
2016 (11957)
2015 (14478)
2014 (10474)
2013 (7560)
2012 (7589)
2011 (7690)
2010 (7486)
Location
Africa (164)
Alabama (66)
Alaska (2)
Arizona (73)
Arkansas (5)
Asia (18413)
Australia (3140)
California (7106)
Canada (1845)
China (774)
Colorado (248)
Connecticut (258)
Delaware (235)
Europe (39436)
Florida (908)
Georgia (209)
Hawaii (2)
Idaho (18)
Illinois (396)
India (36)
Indiana (165)
Iowa (8)
Japan (222)
Kansas (81)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (739)
Massachusetts (5602)
Michigan (115)
Minnesota (249)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (23)
New Jersey (1657)
New Mexico (14)
New York (1767)
North Carolina (829)
North Dakota (6)
Northern California (3488)
Ohio (182)
Oklahoma (11)
Oregon (26)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (224)
South Carolina (9)
Southern California (2818)
Tennessee (44)
Texas (911)
United States (23454)
Utah (96)
Virginia (140)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
283,956 Results for "leap therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
February 5, 2026
·
4 min read
Layoffs
Leap Slashes 75% of Workforce, Explores Strategic Options
In addition to cutting most of its staff, including two C-suite executives, Leap Therapeutics is winding down research and development activities and considering a sale or partnership opportunities.
June 24, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode’s Phase 1 trial
December 12, 2025
·
6 min read
Press Releases
Oncology API Market Set for a Powerful Leap Towards USD 69.55 Billion Revenue
December 5, 2025
·
1 min read
Press Releases
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
October 29, 2025
·
19 min read
Business
Leap Therapeutics Reports First Quarter 2024 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
13 min read
Press Releases
A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients
September 25, 2025
·
4 min read
Business
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the fourth quarter and year ended December 31, 2023.
March 18, 2024
·
12 min read
Deals
Leap Therapeutics Announces $40 Million Private Placement
Leap Therapeutics, Inc. today announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12,660,993 shares of its common stock (“Common Stock”) at a price of $2.82 per share and pre-funded warrants to purchase 1,523,404 shares of Common Stock at a price of $2.819 per share of Common Stock.
April 11, 2024
·
7 min read
1 of 28,396
Next
